organization · Reporting owner
Qiming Venture Partners VI, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alamar Biosciences, Inc.ALMR · Entity 1791 | 10% owner | April 20, 2026 | April 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alamar Biosciences, Inc.
Report date April 20, 2026 · Filed April 22, 2026
Jointly reported with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming GP VIII-HC, LLC, Qiming Venture Partners VIII-HC, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 185,163 |
Reported balance
After 2026-04-20 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-04-20 · Conversion · Acquired 185,163 · Balance 185,163 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F2: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F3: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 6,881,410 |
Reported balance
After 2026-04-20 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2026-04-20 · Conversion · Acquired 6,881,410 · Balance 6,881,410 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F2: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F4: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,605,645 |
Reported balance
After 2026-04-20 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2026-04-20 · Conversion · Acquired 1,605,645 · Balance 1,605,645 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F5: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,922,329 |
Reported balance
After 2026-04-20 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2026-04-20 · Conversion · Acquired 1,922,329 · Balance 1,922,329 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F6: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2026-04-20 · Other · Disposed 185,163 · Balance 0 F7: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F3: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2026-04-20 · Other · Disposed 6,881,410 · Balance 0 F7: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F4: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2026-04-20 · Other · Disposed 1,605,645 · Balance 0 F7: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F5: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2026-04-20 · Other · Disposed 1,922,329 · Balance 0 F7: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F6: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 185,163 |
Reported balance
After 2026-04-20 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2026-04-20 · Other · Acquired 185,163 · Balance 185,163 F7: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F3: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 6,881,410 |
Reported balance
After 2026-04-20 transaction · row 10
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 10 · 2026-04-20 · Other · Acquired 6,881,410 · Balance 6,881,410 F7: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F4: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,605,645 |
Reported balance
After 2026-04-20 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2026-04-20 · Other · Acquired 1,605,645 · Balance 1,605,645 F7: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F5: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,922,329 |
Reported balance
After 2026-04-20 transaction · row 12
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 12 · 2026-04-20 · Other · Acquired 1,922,329 · Balance 1,922,329 F7: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F6: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Series A-3 Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-04-20 · Conversion · Disposed 172,328 · Balance 0 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F3: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Series A-3 Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-04-20 · Conversion · Disposed 6,404,332 · Balance 0 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F4: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Series A-4 Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2026-04-20 · Conversion · Disposed 154,425 · Balance 0 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F3: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Series A-4 Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2026-04-20 · Conversion · Disposed 5,738,971 · Balance 0 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F4: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2026-04-20 · Conversion · Disposed 113,625 · Balance 0 F2: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F3: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2026-04-20 · Conversion · Disposed 4,222,738 · Balance 0 F2: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F4: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2026-04-20 · Conversion · Disposed 3,882,451 · Balance 0 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F5: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2026-04-20 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2026-04-20 · Conversion · Disposed 4,648,194 · Balance 0 F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F6: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date.
F2: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date.
F3: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
F4: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
F5: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
F6: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
F7: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionSeries C Preferred Stock · Derivative | 4,648,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · derivative · entry 20 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 1,922,329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F6 · ownership.nature: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionSeries C Preferred Stock · Derivative | 3,882,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · derivative · entry 19 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 1,605,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F5 · ownership.nature: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionSeries B Preferred Stock · Derivative | 4,222,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · derivative · entry 18 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 1,859,366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F4 · ownership.nature: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionSeries B Preferred Stock · Derivative | 113,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · derivative · entry 17 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 50,031 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F3 · ownership.nature: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionSeries A-4 Preferred Stock · Derivative | 5,738,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · derivative · entry 16 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 2,373,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F4 · ownership.nature: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionSeries A-4 Preferred Stock · Derivative | 154,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · derivative · entry 15 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 63,864 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F3 · ownership.nature: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionSeries A-3 Preferred Stock · Derivative | 6,404,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · derivative · entry 14 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 2,648,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F4 · ownership.nature: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionSeries A-3 Preferred Stock · Derivative | 172,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · derivative · entry 13 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 71,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F3 · ownership.nature: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherCommon Stock | 1,922,329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 12 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,922,329 F7 · kind: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F7 · price: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F6 · ownership.nature: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherCommon Stock | 1,605,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 11 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,605,645 F7 · kind: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F7 · price: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F5 · ownership.nature: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherCommon Stock | 6,881,410 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 10 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,881,410 F7 · kind: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F7 · price: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F4 · ownership.nature: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherCommon Stock | 185,163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 9 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 185,163 F7 · kind: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F7 · price: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F3 · ownership.nature: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherClass B Common Stock | 1,922,329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 8 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F7 · kind: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F7 · price: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F6 · ownership.nature: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherClass B Common Stock | 1,605,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 7 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F7 · kind: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F7 · price: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F5 · ownership.nature: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherClass B Common Stock | 6,881,410 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 6 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F7 · kind: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F7 · price: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F4 · ownership.nature: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherClass B Common Stock | 185,163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 5 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F7 · kind: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F7 · price: Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock. F3 · ownership.nature: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionClass B Common Stock | 1,922,329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 4 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,922,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F6 · ownership.nature: These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionClass B Common Stock | 1,605,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 3 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,605,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F5 · ownership.nature: These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionClass B Common Stock | 6,881,410 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 2 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,881,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F2 · price: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F4 · ownership.nature: These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 16:16 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | ConversionClass B Common Stock | 185,163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001231919-26-000392 · form4-04222026_080434.xml · nonDerivative · entry 1 Qiming Corporate GP VI, Ltd. · CIK 0002059127 · 10% owner Qiming Managing Directors Fund VI, L.P. · CIK 0001733282 · 10% owner Qiming Venture Partners VI, L.P. · CIK 0001733278 · 10% owner Qiming GP VIII, LLC · CIK 0002129740 · 10% owner Qiming Venture Partners VIII Investments, LLC · CIK 0002129618 · 10% owner Qiming GP VIII-HC, LLC · CIK 0002129671 · 10% owner Qiming Venture Partners VIII-HC, L.P. · CIK 0001910025 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 185,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. F2 · price: Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. F3 · ownership.nature: These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.